Works matching Thiotepa

Results: 559
    1
    2

    Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 2, p. 226, doi. 10.1002/cncr.29023
    By:
    • Chen, Yi‐Bin;
    • Batchelor, Tracy;
    • Li, Shuli;
    • Hochberg, Ephraim;
    • Brezina, Mark;
    • Jones, Sooae;
    • Del Rio, Candice;
    • Curtis, Morgan;
    • Ballen, Karen K.;
    • Barnes, Jeffrey;
    • Chi, Andrew S.;
    • Dietrich, Jorg;
    • Driscoll, Jessica;
    • Gertsner, Elizabeth R.;
    • Hochberg, Fred;
    • LaCasce, Ann S.;
    • McAfee, Steven L.;
    • Spitzer, Thomas R.;
    • Nayak, Lakshmi;
    • Armand, Philippe
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Published in:
    European Journal of Haematology, 2016, v. 96, n. 1, p. 90, doi. 10.1111/ejh.12553
    By:
    • Eder, Sandra;
    • Labopin, Myriam;
    • Arcese, William;
    • Or, Reuven;
    • Majolino, Ignazio;
    • Bacigalupo, Andrea;
    • Rosa, Gennaro;
    • Volin, Liisa;
    • Beelen, Dietrich;
    • Veelken, Hendrik;
    • Schaap, Nicolaas P. M.;
    • Kuball, Jurgen;
    • Cornelissen, Jan;
    • Nagler, Arnon;
    • Mohty, Mohamad
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).

    Published in:
    2020
    By:
    • Esquirol, Albert;
    • Querol, Sergi;
    • Garcia-Cadenas, Irene;
    • Novelli, Silvana;
    • Garrido, Ana;
    • Saavedra, Silvana;
    • Moreno, Carol;
    • Granell, Miquel;
    • Caballero, Ana;
    • Brunet, Salut;
    • Briones, Javier;
    • Martino, Rodrigo;
    • Sierra, Jorge
    Publication type:
    journal article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party.

    Published in:
    2020
    By:
    • El-Cheikh, Jean;
    • Labopin, Myriam;
    • Al-Chami, Farouk;
    • Bazarbachi, Ali;
    • Angelucci, Emanuele;
    • Santarone, Stella;
    • Bonifazi, Francesca;
    • Carella, Angelo Michele;
    • Castagna, Luca;
    • Bruno, Benedetto;
    • Iori, Anna Paola;
    • La Nasa, Giorgio;
    • Savani, Bipin;
    • Nagler, Arnon;
    • Mohty, Mohamad
    Publication type:
    journal article
    49
    50